2022-07-01 2023-06-30 false No description of principal activity Capium Accounts Production 1.1 13431016 bus:AbridgedAccounts 2022-07-01 2023-06-30 13431016 bus:Micro-entities 2022-07-01 2023-06-30 13431016 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 13431016 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 13431016 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 13431016 2022-07-01 2023-06-30 13431016 2023-06-30 13431016 bus:RegisteredOffice 2022-07-01 2023-06-30 13431016 core:WithinOneYear 2023-06-30 13431016 core:AfterOneYear 2023-06-30 13431016 bus:Director1 2022-07-01 2023-06-30 13431016 bus:Director1 2023-06-30 13431016 bus:Director1 2021-06-01 2022-06-30 13431016 bus:Director2 2022-07-01 2023-06-30 13431016 bus:Director2 2023-06-30 13431016 bus:Director2 2021-06-01 2022-06-30 13431016 bus:Director3 2022-07-01 2023-06-30 13431016 bus:Director3 2023-06-30 13431016 bus:Director3 2021-06-01 2022-06-30 13431016 bus:Director4 2022-07-01 2023-06-30 13431016 bus:Director4 2023-06-30 13431016 bus:Director4 2021-06-01 2022-06-30 13431016 2021-06-01 13431016 bus:CompanySecretary1 2022-07-01 2023-06-30 13431016 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 13431016 2021-06-01 2022-06-30 13431016 2022-06-30 13431016 core:WithinOneYear 2022-06-30 13431016 core:AfterOneYear 2022-06-30 13431016 bus:EntityAccountantsOrAuditors 2021-06-01 2022-06-30 13431016 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 13431016 bus:OrdinaryShareClass1 2023-06-30 13431016 bus:OrdinaryShareClass1 2021-06-01 2022-06-30 13431016 bus:OrdinaryShareClass1 2022-06-30 13431016 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 13431016 core:CostValuation core:Non-currentFinancialInstruments 2022-06-30 13431016 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-06-30 13431016 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 13431016 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-06-30 13431016 core:Non-currentFinancialInstruments 2023-06-30 13431016 core:Non-currentFinancialInstruments 2022-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13431016
England and Wales

 

 

 

ABC'S PHARMA LTD


Abridged Accounts
 


Period of accounts

Start date: 01 July 2022

End date: 30 June 2023
  2023   2022
    £ £   £ £
Fixed assets   471,767      471,767 
Current assets 26,033      3,208   
Creditors: amount falling due within one year (104,610)     (135,417)  
Net current liabilities   (78,577)     (132,209)
Total assets less current liabilities   393,190      339,558 
Creditors: amount falling due after more than one year   (321,245)     (322,388)
Net assets   71,945      17,170 
 

         
Capital and reserves   71,945      17,170 
 
NOTES TO THE ACCOUNTS

General Information
ABC's Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 13431016, registration address 23 Arbroath Green, Watford, WD19 7QT.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 0 (2022 : 0).


For the year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 31 March 2024 and were signed on its behalf by:


--------------------------------
Ashishkumar Patel
Director
1